MedTrace Logo

Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.

NCT02452099 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2017-01-18

No results posted yet for this study

Summary

The main aim of the study was to evaluate the clinical impact of different DMSO concentrations in cryopreservation mixture (5%, 7.5%, 10%) on reconstitution of hematopoiesis after autologous hematopoietic stem cell transplantation.

Conditions

Interventions

PROCEDURE

Cryopreservation of HSCs using 5% DMSO concentration

Cryopreservation of HSCs obtained by leukapheresis will be performed using 5% DMSO concentration.

PROCEDURE

Cryopreservation of HSCs using 7,5% DMSO concentration

Cryopreservation of HSCs obtained by leukapheresis will be performed using 7,5% DMSO concentration.

PROCEDURE

Cryopreservation of HSCs using 10% DMSO concentration

Cryopreservation of HSCs obtained by leukapheresis will be performed using 10% DMSO concentration.

Sponsors & Collaborators

  • Maria Sklodowska-Curie National Research Institute of Oncology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-08-31
Completion
2016-12-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02452099 on ClinicalTrials.gov